Compare · CHPT vs ZBH
CHPT vs ZBH
Side-by-side comparison of ChargePoint Holdings Inc. (CHPT) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- CHPT operates in Consumer Discretionary, while ZBH operates in Health Care - the two are in different parts of the market.
- ZBH is the larger of the two at $18.00B, about 92.7x CHPT ($194.1M).
- ZBH has been more active in the news (13 items in the past 4 weeks vs 7 for CHPT).
- Both have 25 recent analyst ratings on file.
- Company
- ChargePoint Holdings Inc.
- Zimmer Biomet Holdings Inc.
- Price
- -
- -
- Market cap
- $194.1M
- $18.00B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- News (4w)
- 7
- 13
- Recent ratings
- 25
- 25
ChargePoint Holdings Inc.
ChargePoint Holdings, Inc. provides electric vehicle (EV) charging networks and charging solutions in the United States. It offers a portfolio of hardware, software, and services for commercial, fleet, and residential customers. The company was founded in 2007 and is headquartered in Campbell, California.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest CHPT
- ChargePoint Holdings Inc. filed SEC Form 8-K: Other Events
- President and CEO Wilmer Richard covered exercise/tax liability with 7,631 shares, decreasing direct ownership by 2% to 496,462 units (SEC Form 4)
- CAO Novruzova Natella Fakhradovna sold $14,632 worth of shares (1,484 units at $9.86), decreasing direct ownership by 5% to 28,213 units (SEC Form 4) (withholding tax)
- CCXO Singh Jagdeep Ca sold $58,815 worth of shares (5,965 units at $9.86), decreasing direct ownership by 3% to 182,381 units (SEC Form 4) to satisfy withholding tax
- General Counsel Batill Eric sold $42,418 worth of shares (4,302 units at $9.86), decreasing direct ownership by 3% to 139,329 units (SEC Form 4) (tax withholding)
- CFO Khetani Mansi sold $48,620 worth of shares (4,931 units at $9.86), decreasing direct ownership by 3% to 174,417 units (SEC Form 4) to cover taxes
- Handshake Unveils AI Skills Studio for Job Seekers: NYSE Content Update
- SEC Form 10-Q filed by ChargePoint Holdings Inc.
- ChargePoint Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- ChargePoint Accelerates European Growth Strategy with Appointment of John Saffrett as EVP and Managing Director, Europe
Latest ZBH
- ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT
- Barclays initiated coverage on Zimmer Biomet with a new price target
- Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results
- SEC Form 4 filed by Zimmer Biomet Holdings Inc.
- SEC Form 3 filed by Zimmer Biomet Holdings Inc.
- SEC Form 3 filed by Zimmer Biomet Holdings Inc.
- SEC Form 4 filed by Director Farrell Michael J.
- SEC Form 4 filed by Director Hagemann Robert
- SEC Form 4 filed by Director Higgins Arthur J
- SEC Form 4 filed by Director Shapiro Louis